Article Summary
韩伟1 刘杨2 齐蕾1 单丽辉1 柴翠翠1 王立峰1.胃癌组织中Tenascin、MVD、Ki-67 的表达及其临床意义[J].现代生物医学进展英文版,2011,11(19):3767-3770.
胃癌组织中Tenascin、MVD、Ki-67 的表达及其临床意义
Expression of Tenascin, MVD, Ki-67 in Gastric Adenocarcinoma and TheirClinical Significance
  
DOI:
中文关键词: 胃癌  Tenascin  微血管密度  Ki-67  免疫组织化学
英文关键词: Gastric Adenocarcinoma  Tenascin  Microvascular Density  Ki-67  Immunohistochemistry
基金项目:哈尔滨市科技创新人才专项资金项目(RC2010XK004048)
Author NameAffiliation
HAN Wei1, LIU Yang2, QI Lei1, SHAN Li-hui1, CHAI Cui-cui1, WANG Li-feng1 哈尔滨医科大学附属第一临床医院病理科 
Hits: 718
Download times: 1188
中文摘要:
      目的:探讨胃癌组织中Tenascin 蛋白、微血管密度(microvascular density, MVD)、Ki-67 的表达及其与临床病理特征的关系。 方法:采用免疫组化Elivision 法检测70 例胃癌组织和20 例癌旁正常组织中Tenascin、CD34 和Ki-67 的表达。结果:①正常胃黏 膜上皮Tenascin 阴性,胃癌中的Tenascin 主要表达于肿瘤相关纤维母细胞的胞质中,且与胃癌的Lauren 分型、分化程度、临床分 期、淋巴结转移显著相关(P<0.05);②胃癌中MVD 和Ki-67-LI(标记指数)均高于正常胃黏膜(P<0.001),且均与胃癌的临床分 期、浸润深度、淋巴结转移显著相关(P<0.05);结论:胃癌组织中Tenascin 可抑制胃癌的演进,MVD 及Ki-67 可作为胃癌患者预 后的预测指标,联合检测胃癌组织Tenascin、MVD、Ki-67 的表达情况,对于进一步了解胃癌的生物学行为和判断预后具有一定的 临床价值与意义。
英文摘要:
      Objective: To investgate the expression of Tenascin, microvascular density (MVD), Ki-67 in gastric carcinoma and their relationship with clinicopathologic features. Methods: The expression of Tenascin, CD34 and Ki-67 in 70 cases of gastric carcinoma and 20 cases of normal gastric tissue was detected by immunohistochemistry. Results:① Tenascin was mainly expressed in tumor associated fibroblasts and the level of its expression was associated with Lauren classification, differentiation degree, TNM tumour stage and lymph node metastases (P<0.05);② The expression of MVD and Ki-67-LI was significantly higher in gastric cancer than in normal gastric tissue (P<0.001), both of them were respectively correlated with the TNM tumour stage, the depth of tumour invasion and lymph node metastases (P<0.05). Conclusions: Tenascin may inhibit the development of gastric cancer. Quantitation of MVD and Ki-67 were useful prognostic marker for gastric cancer patients. Therefore, the detection of tenascin, MVD and Ki-67 may be valuable to evaluate biological behavior for patients with gastric cancer during clinical treatment.
View Full Text   View/Add Comment  Download reader
Close